Cancer Research UK to invest £226m in cancer research
Cancer Research UK has announced an investment of £190m in 13 centres over the next five years.
Additionally, £36m will be invested by Cancer Research and the Departments of Health over five years into 18 Experimental Cancer Medicine Centres (ECMCs) for adult patients and also a network of centres for children.
The investment is aimed at accelerating advances in research and support clinical trials to bring lifesaving treatments to patients.
Cancer Research centres bring together research teams from local universities, NHS hospitals and other research organisations, which operate as a single network focusing on translational research.
Cancer Research UK strategy and research funding executive director Dr Iain Foulkes said: “This is the largest investment we have ever made into the centres and we are incredibly proud of that.
“It’s also the first time we have co-funded the paediatric ECMC network with the National Institute for Health Research and the Chief Scientist Office, Scotland, which will help boost research to develop smarter, kinder treatments for children.”
“This is particularly important for hard to treat cancers like pancreatic, oesophageal, lung and brain tumours.”
The ECMCs will bring better treatments to cancer patients in the country through the adult, as well as children’s network of centres, which help give access to people with cancer to new treatments and medicine by testing new methods of detecting and monitoring the disease.
Cancer Research UK chief executive Harpal Kumar said: “Cancer Research UK’s projections are that we will reach more than 500,000 new diagnoses of cancer a year in the UK by 2035.
“By that time, our goal is that three in four people will survive their cancer. Funding these centres is one of the charity’s most important strategic priorities, and one which will help us reach this ambition.
Image: Cancer Research UK chief executive Harpal Kumar. Photo: courtesy of Cancer Research UK.